|
End-of-day quote
Shenzhen S.E.
2026-10-26
|
5-day change | 1st Jan Change | ||
| 30.24 CNY | -0.10% |
|
-0.95% | -9.87% |
| 09-04 | ApicHope Pharmaceutical Obtains Approval for Sertraline Oral Solution in China | MT |
| 09-04 | ApicHope Pharmaceutical's Gout Drug Meets Primary Endpoint in Drug Trial | MT |
| Market Cap | 13.56B 2.03B 1.82B 1.68B 1.52B 2.85B 193B 2.9B 20.24B 8.01B 101B 7.63B 7.47B 320B | P/E 2026 * |
26.1x | P/E 2027 * | -131x |
|---|---|---|---|---|---|
| Enterprise Value | 13.56B 2.03B 1.82B 1.68B 1.52B 2.85B 193B 2.9B 20.24B 8.01B 101B 7.63B 7.47B 320B | EV / Sales 2026 * |
12.6x | EV / Sales 2027 * | 10.8x |
| Free-Float |
31.84% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 day | -0.10% | ||
| 1 week | -0.95% | ||
| Current month | -9.11% | ||
| 1 month | -8.92% | ||
| 3 months | -10.66% | ||
| 6 months | -19.34% | ||
| Current year | -9.87% |
| 1 week | 28.41 |  | 31.52 |
| 1 month | 28.41 | | 33.8 |
| Current year | 28.41 | | 45.88 |
| 1 year | 28.41 | | 56.88 |
| 3 years | 12.74 | | 81.48 |
| 5 years | 12.74 | | 81.48 |
| 10 years | 7.58 | | 81.48 |
| Manager | Title | Age | Since |
|---|---|---|---|
Han Xiong Li
CEO | Chief Executive Officer | 52 | 2015-11-10 |
Hui Xing Zhang
DFI | Director of Finance/CFO | 60 | 2015-11-10 |
Xiao Dong Liu
IRC | Investor Relations Contact | 38 | 2020-12-30 |
| Director | Title | Age | Since |
|---|---|---|---|
Ke Jian Zhang
BRD | Director/Board Member | 70 | 2024-06-30 |
Han Xiong Li
CHM | Chairman | 52 | 2015-11-10 |
Han Dong Li
BRD | Director/Board Member | 58 | 2015-11-10 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 1/5/26 | Buy | Director | 4,200 | 0.0010% | ||
| 11/24/25 | Buy | Director | 7,000 | 0.0017% | ||
| 9/1/23 | Buy | 20,000 | 0.0089% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.10% | -0.95% | -42.09% | +14.07% | 2.04B | |
| +0.45% | +3.13% | +54.96% | +125.16% | 1,135B | |
| +0.94% | +4.93% | +39.86% | +78.72% | 635B | |
| +0.39% | +1.44% | +25.77% | +97.48% | 505B | |
| +1.43% | +4.31% | +46.20% | +67.12% | 378B | |
| -3.21% | -2.10% | +60.72% | +33.22% | 358B | |
| -0.41% | +2.64% | +22.48% | +49.82% | 295B | |
| +0.23% | +3.66% | +2.57% | +23.69% | 266B | |
| +1.22% | +4.63% | +52.40% | +64.85% | 237B | |
| +1.70% | +3.67% | +31.21% | +102.15% | 193B | |
| Average | +0.23% | +2.24% | +29.41% | +65.63% | 400.57B | |
| Weighted average by Cap. | +0.42% | +2.84% | +41.36% | +83.57% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.08B 162M 145M 134M 121M 227M 15.4B 231M 1.61B 637M 8.05B 608M 595M 25.5B | 1.26B 189M 169M 156M 141M 264M 17.94B 269M 1.88B 742M 9.38B 708M 693M 29.71B |
| Net income | 526M 78.83M 70.49M 65.22M 59.05M 111M 7.5B 112M 785M 310M 3.92B 296M 290M 12.42B | -102M -15.29M -13.67M -12.65M -11.45M -21.43M -1.45B -21.78M -152M -60.2M -761M -57.38M -56.15M -2.41B |
| Net Debt | - | - |
Employees
1,294
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-26 | CN¥30.24 | -0.10% | 2,734,338 |
| 26-10-23 | CN¥30.27 | +2.47% | 4,424,788 |
| 26-10-22 | CN¥29.54 | -4.28% | 3,674,999 |
| 26-10-21 | CN¥30.86 | -0.71% | 2,771,887 |
| 26-10-20 | CN¥31.08 | +1.80% | 3,587,042 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- 300723 Stock
Select your edition
All financial news and data tailored to specific country editions
